ZYME compared with ARDX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZYMEZymeworks Inc.

Mkt capRevenueRevenue

ARDXArdelyx, Inc.

Mkt capRevenueRevenue

Compare

ZYMEZymeworks Inc.

ARDXArdelyx, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZYME 11

JNJJ&Jcustomer

BMYCelgene (now BMS)customer

JAZZJazz Pharmaceuticals Irelandcustomer

RPRXRoyalty Pharmacustomer

7 more · ZYME chain ›

Shared 0

No shared counterparties.

Only ARDX 4

—Knightunlistedsupplier

—Kyowa Kirinunlistedsupplier

—Fosun Pharmaunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

METiS

unlistedcustomer

ZYMEZymeworks Inc.

28.78· pre 28.95· delayed

Mkt cap$2.1BRevenue$5MQ2 FY26Revenue$106MFY25

ARDXArdelyx, Inc.

2.99· pre 3.00· delayed

Pre-marketNov 6 '26delayed

Mkt cap$827.0MRevenue$128MQ3 FY26Revenue$407MFY25

Compare

Pre-marketNov 6 '26delayed

ZYMEZymeworks Inc.

ARDXArdelyx, Inc.

28.78pre 28.95delayed

Price

2.99pre 3.00delayed

$2.1B

Mkt cap

$827.0M

Q2 FY26$5M

Revenue

$128MQ3 FY26

FY25$106M

Revenue

$407MFY25

ZYME28.78vsARDX2.99Pre-marketNov 6 '26delayed